Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jul;49(5):996-1023.
doi: 10.1177/0192623320985045. Epub 2021 Feb 12.

A Review of Specific Biomarkers of Chronic Renal Injury and Their Potential Application in Nonclinical Safety Assessment Studies

Leslie A Obert  1 , Susan A Elmore  2 , Daniela Ennulat  1 , Kendall S Frazier  3
Affiliations
Review

A Review of Specific Biomarkers of Chronic Renal Injury and Their Potential Application in Nonclinical Safety Assessment Studies

Leslie A Obert et al. Toxicol Pathol. 2021 Jul.

Abstract

A host of novel renal biomarkers have been developed over the past few decades which have enhanced monitoring of renal disease and drug-induced kidney injury in both preclinical studies and in humans. Since chronic kidney disease (CKD) and acute kidney injury (AKI) share similar underlying mechanisms and the tubulointerstitial compartment has a functional role in the progression of CKD, urinary biomarkers of AKI may provide predictive information in chronic renal disease. Numerous studies have explored whether the recent AKI biomarkers could improve upon the standard clinical biomarkers, estimated glomerular filtration rate (eGFR), and urinary albumin to creatinine ratio, for predicting outcomes in CKD patients. This review is an introduction to alternative assays that can be utilized in chronic (>3 months duration) nonclinical safety studies to provide information on renal dysfunction and to demonstrate specific situations where these assays could be utilized in nonclinical drug development. Novel biomarkers such as symmetrical dimethyl arginine, dickkopf homolog 3, and cystatin C predict chronic renal injury in animals, act as surrogates for GFR, and may predict changes in GFR in patients over time, ultimately providing a bridge from preclinical to clinical renal monitoring.

Keywords: DKK3; SDMA; biomarkers; chronic renal injury; cystatin C; nonclinical safety; uromodulin.

PubMed Disclaimer

Conflict of interest statement

Declaration of Conflicting Interests

The authors declared no potential, real or perceived conflicts of interest with respect to the research, authorship, and/or publication of this article.

Figures

Figure 1:
Figure 1:
Renal Injury Biomarkers Along the Continuum of Animal Toxicity Studies. Acute renal injury biomarkers (KIM-1, NGAL, B2M, urine CysC) have shown some utility in monitoring the progression of acute to chronic injury, but often their successful usage in subacute to subchronic renal injury has been dependent upon type of injury and/or species (italicized). In addition to the standard renal functional biomarkers (ALB, Protein, mGFR), other biomarkers have shown promise in predicting and monitoring subacute to subchronic (SMDA, DKK3, serum CysC, UMOD) or chronic renal injury (SDMA, DKK3, serum CysC) in animal toxicity studies. u: urine, s: serum, p: plasma, kidney injury molecule 1: KIM-1, neutrophil gelatinase-associated lipocalin: NGAL, beta 2 macroglobulin: B2M, cystatin C: CysC, symmetrical dimethyl arginine: SDMA, dickkopf homolog 3: DKK3, uromodulin: UMOD, albumin: ALB, measured glomerular filtration rate: mGFR.
See this image and copyright information in PMC

References

    1. Redfern WS, Ewart E, Hammond TG, et al. Impact and frequency of different toxicities throughout the pharmaceutical life cycle. Toxicologist. 2010;114:1081.
    1. Troth SP, Vlasakova K, Amur S, Amin RP, Glaab WE. Translational Safety Biomarkers of Kidney Injury. Semin Nephrol. 2019;39(2):202–214. - PubMed
    1. Ennulat D, Ringenberg M, Frazier KS. Toxicologic Pathology Forum Opinion Paper*: Recommendations for a Tiered Approach to Nonclinical Mechanistic Nephrotoxicity Evaluation. Toxicol Pathol. 2018;46(6):636–646. - PubMed
    1. Frazier KS, Ryan AM, Peterson RA, Obert LA. Kidney Pathology and Investigative Nephrotoxicology Strategies Across Species. Semin Nephrol. 2019;39(2):190–201. - PubMed
    1. Hosten AO. BUN and Creatinine. In: rd, Walker HK, Hall WD, Hurst JW, eds. Clinical Methods: The History, Physical, and Laboratory Examinations. 3rd ed. Boston: Butterworths; 1990. - PubMed

Publication types